Clinical Trials Browser

NIH × Ovarian Neoplasms × eribulin × Clear all

NCT00410553 2018-10-03

Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery

Phase 1 Completed

Ovarian Neoplasms